4//SEC Filing
Sumner Michael John 4
Accession 0001055726-24-000002
CIK 0001055726other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 5:03 PM ET
Size
8.2 KB
Accession
0001055726-24-000002
Insider Transaction Report
Form 4
Sumner Michael John
Chief Medical Officer
Transactions
- Award
Restricted Stock Unit
2024-02-28+15,029→ 15,029 total→ Common Stock (15,029 underlying) - Award
Common Stock Option
2024-02-28+18,750→ 18,750 totalExercise: $8.46From: 2024-02-28Exp: 2034-02-28→ Common Stock (18,750 underlying)
Footnotes (2)
- [F1]The vesting schedule for the 18,750 options is as follows: 4,688 shares vested on February 28, 2024; 4,688 shares will vest on February 28, 2025; 4,687 shares will vest on February 28, 2026; and 4,687 shares will vest on February 28, 2027.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units is as follows: 5,010 shares will vest on February 26, 2025; 5,010 shares will vest on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
Documents
Issuer
INOVIO PHARMACEUTICALS, INC.
CIK 0001055726
Entity typeother
Related Parties
1- filerCIK 0001936799
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 5:03 PM ET
- Size
- 8.2 KB